Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026)
Neuroone Medical Technologies (NMTC) reported Change in Account Payables of $380240.0 for Q1 2026, up 296.81% year-over-year from $95824.0 in Q1 2025, and up 186.42% sequentially from -$439992.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026) Analysis & Trends
Neuroone Medical Technologies has disclosed Change in Account Payables across 10 years of filings, most recently posting $380240.0 for Q1 2026.
- Quarterly Change in Account Payables rose 296.81% year-over-year to $380240.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99346.0 (up 39.97% YoY) and the FY2025 annual result came in at $239983.0, up 258.22% from the prior year.
- Change in Account Payables improved to $380240.0 in Q1 2026, from -$439992.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $602635.0 in Q3 2022 and bottomed at -$439992.0 in Q4 2025.
- The 5-year median for Change in Account Payables is -$14939.0 (2024), against an average of $13194.2.
- The widest YoY moves for Change in Account Payables: up 3746.27% in 2025, down 2845.26% in 2025.
- Neuroone Medical Technologies' Change in Account Payables stood at -$154098.0 in 2022, then jumped by 151.61% to $79527.0 in 2023, then slumped by 118.78% to -$14939.0 in 2024, then tumbled by 2845.26% to -$439992.0 in 2025, then soared by 186.42% to $380240.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $380240.0, -$439992.0, and $526943.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | 380,240.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380,240.00 |
| Mar 31, 2026 | 380,240.00 |
| Dec 31, 2025 | -439,992.00 |
| Dec 31, 2025 | -439,992.00 |
| Sep 30, 2025 | 526,943.00 |
| Sep 30, 2025 | 526,943.00 |
| Jun 30, 2025 | -367,845.00 |
| Jun 30, 2025 | -367,845.00 |
| Mar 31, 2025 | 95,824.00 |
| Mar 31, 2025 | 95,824.00 |
| Dec 31, 2024 | -14,939.00 |
| Dec 31, 2024 | -14,939.00 |
| Sep 30, 2024 | 22,206.00 |
| Sep 30, 2024 | 22,206.00 |
| Jun 30, 2024 | -32,112.00 |
| Jun 30, 2024 | -32,112.00 |
| Mar 31, 2024 | -2,628.00 |
| Mar 31, 2024 | -2,628.00 |
| Dec 31, 2023 | 79,527.00 |
| Dec 31, 2023 | 79,527.00 |